🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,067 results for “Hospital” Clear

  1. NK510

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC

    phase 1 small molecule active

    1 trial

  2. Neoadjuvant chemotherapy

    Hospital Authority, Hong Kong

    Squamous Cell Carcinoma of Oral Cavity

    phase 1 small molecule completed

    1 trial

  3. NeuroRegen scaffold with BMMCs or MSCs transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Spinal Cord Injury

    phase 1 mab active

    1 trial

  4. Nicorette Extra Mint 2 mg Gum

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tobacco Dependence

    phase 1 small molecule completed

    1 trial

  5. Nivolumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Effect of Drug

    phase 1 small molecule active

    1 trial

  6. OPB-51602

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma

    phase 1 small molecule terminated

    1 trial

  7. Octreotide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Enterocutaneous Fistulas

    phase 1 small molecule completed

    1 trial

  8. Olfactory ensheathing cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Infarction, Middle Cerebral Artery

    phase 1 other active

    1 trial

  9. Olverembatinib, APG-2575, Dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lymphoblastic Leukemia, Acute, Childhood

    phase 1 small molecule active

    1 trial

  10. Omega 3 fatty acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Male Infertility Due to Hypospermatogenesis

    phase 1 small molecule active

    1 trial

  11. Oncolytic Virus SDJ001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Malignant Tumor

    phase 1 small molecule active

    1 trial

  12. Oxidized regenerated cellulose(ORC)

    Hospital Authority, Hong Kong

    Thyroidectomy

    phase 1 small molecule completed

    1 trial

  13. Oxycodone (OxyNorm®) Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pain

    phase 1 small molecule completed

    1 trial

  14. Oxycodone Tamper Resistant

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Pain

    phase 1 small molecule completed

    3 trials

  15. Oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oxytocin Effect on Memory Performance During Phase 1

    phase 1 small molecule completed

    1 trial

  16. Oxytocin lower does (24IU)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Adult Male

    phase 1 small molecule active

    1 trial

  17. Oxytocin lower dose (24IU)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healhty

    phase 1 small molecule active

    1 trial

  18. Oxytocin nasal spray

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule completed

    1 trial

  19. PEGylated recombinant human interferon alpha-2b injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    phase 1 small molecule active

    1 trial

  20. PRG-1801

    Hospital Authority, Hong Kong

    Immune Thrombocytopenia

    phase 1 small molecule active

    1 trial

  21. PRG2302

    The First People's Hospital of Lianyungang

    Acute Lymphoblastic Leukemia

    phase 1 small molecule active

    1 trial

  22. Paclitaxel

    Hospital Authority, Hong Kong

    Ovarian Cancer

    phase 1 small molecule active

    1 trial

  23. Pemetrexed

    The First People's Hospital of Lianyungang

    Leptomeningeal Metastases

    phase 1 small molecule completed

    1 trial

  24. Phase Ib of Cyclophosphamide, Pomalidomide, Dexamethasone and Daratumumab (CPD-DARA) in patients with relapsed/refractory multiple myeloma. (The CPD-DARA Study).

    Ningbo Cancer Hospital

    Relapsed/ refractory multiple myeloma

    phase 1 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources